NDT Advance Access originally published online on February 7, 2006
Nephrology Dialysis Transplantation 2006 21(4):850-853; doi:10.1093/ndt/gfl019
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author [2006]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Editorial Comment
Inflammation and hypertension: the search for a link
Dipartimento di Medicina Clinica e Sperimentale, Università di Padova, Italy
Correspondence and offprint requests to: Prof. Paolo Pauletto, Dipartimento di Medicina Clinica e Sperimentale Università di Padova and Medicina Interna I, Ospedale CaFoncello, Via Ospedale, 31100 Treviso, Italy. Email: ppauletto@ulss.tv.it
Keywords: atherosclerosis; arterial stiffness; cytokines; hypertension; inflammation; smooth muscle cells
| The first 150 words of the full text of this article appear below. |
| Introduction |
|---|
The last decade has shown an increase in the relevance of inflammation and its mediators in vascular biology; thus, the role of inflammation during atherogenesis is now a matter of intense investigation [1,2]. Basic science studies proved that elements belonging to both innate and adaptive immunity can be involved in the formation, progression and complication of atherosclerosis [2]. Plasma levels of circulating inflammatory molecules, such as C-reactive protein (CRP) and interleukin-6 (IL-6), have been shown to be predictive of future cardiovascular disease (CVD), and drugs which modify their levels can reduce the risk of myocardial infarction and stroke [3]. It has been known for years that hypertension represents an important risk factor for CVD and its treatment is mandatory to prevent future adverse events. To date, however, very little data are available concerning a potential link between inflammation and hypertension. Inflammation and
| Epidemiological evidence |
|---|
| Potential pathophysiological connection |
|---|
| Conclusions |
|---|
This article has been cited by other articles:
![]() |
L. A. Calo, M. Puato, S. Schiavo, M. Zanardo, C. Tirrito, E. Pagnin, G. Balbi, P. A. Davis, P. Palatini, and P. Pauletto Absence of vascular remodelling in a high angiotensin-II state (Bartter's and Gitelman's syndromes): implications for angiotensin II signalling pathways Nephrol. Dial. Transplant., September 1, 2008; 23(9): 2804 - 2809. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Bivol, R. K. Berge, and B. M. Iversen Tetradecylthioacetic acid prevents the inflammatory response in two-kidney, one-clip hypertension Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2008; 294(2): R438 - R447. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Shen, D. K. Arnett, J. M. Peacock, L. D. Parnell, A. Kraja, J. E. Hixson, M. Y. Tsai, C.-Q. Lai, E. K. Kabagambe, R. J. Straka, et al. Interleukin1{beta} Genetic Polymorphisms Interact with Polyunsaturated Fatty Acids to Modulate Risk of the Metabolic Syndrome J. Nutr., August 1, 2007; 137(8): 1846 - 1851. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Alvarez, J. V. Perez-Giron, R. Hernanz, A. M. Briones, A. Garcia-Redondo, A. Beltran, M. J. Alonso, and M. Salaices Losartan Reduces the Increased Participation of Cyclooxygenase-2-Derived Products in Vascular Responses of Hypertensive Rats J. Pharmacol. Exp. Ther., April 1, 2007; 321(1): 381 - 388. [Abstract] [Full Text] [PDF] |
||||



